We are proud to announce the selection of Dr. Reshma Ramracheya for an oral presentation at the prestigious Third European Association for the Study of Diabetes Incretin Study Group Meeting. Our Head of Pharmaceutical Operations will be discussing what is “known, new, controversial” in the incretin field so as to identify key questions that need to be addressed in clinical and fundamental science and propose key clinical trials.

Latest News
  • 29 May 2020 COVID-19 Response
  • 20 May 2020 Happy International Clinical Trials Day!
  • 17 April 2020 CIDP accelerates its digitalization programme to cope with COVID-19 challenges
Archives

Time Zone

Choose a centre